Breaking News Instant updates and real-time market news.

RTN

Raytheon

$212.22

1.47 (0.70%)

, LMT

Lockheed Martin

$336.32

1.07 (0.32%)

12:33
03/20/18
03/20
12:33
03/20/18
12:33

President Trump says arms race 'getting out of control'

President Trump said his conversation with President Putin today included a conversation about the arms race between the two companies. The race is "getting out of control," Trump said during a press conference at the White House. Trump added that the U.S. will remain well ahead of other countries in terms of defense. He noted the U.S. is spending $700B this year on defense. Trump plans on meeting with Putin in the not too distant future. Publicly traded companies in the defense space include BAE Systems (BAESY), Boeing (BA), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC), Raytheon (RTN) and United Technologies (UTX).

RTN

Raytheon

$212.22

1.47 (0.70%)

LMT

Lockheed Martin

$336.32

1.07 (0.32%)

GD

General Dynamics

$225.75

1.85 (0.83%)

UTX

United Technologies

$127.68

0.48 (0.38%)

NOC

Northrop Grumman

$348.24

3.31 (0.96%)

BAESY

BAE Systems

$33.04

0.162 (0.49%)

BA

Boeing

$337.62

5.86 (1.77%)

  • 20

    Mar

  • 30

    May

RTN Raytheon
$212.22

1.47 (0.70%)

01/16/18
WELS
01/16/18
NO CHANGE
Target $215
WELS
Outperform
Raytheon price target raised to $215 from $202 at Wells Fargo
Wells Fargo analyst Sam Pearlstein price target for Raytheon to $215 from $202 ahead of quarterly results and to reflect tax reform. The analyst reiterates an Outperform rating on the shares.
01/29/18
BERN
01/29/18
NO CHANGE
Target $255
BERN
Outperform
Raytheon price target raised to $255 from $231 at Bernstein
Bernstein analyst Douglas Harned raised his price target for Raytheon to $255 from $231 based on a strong outlook for 2018 and subsequent years. The analyst reiterates an Outperform rating on the shares.
03/02/18
BERN
03/02/18
NO CHANGE
Target $255
BERN
Outperform
Raytheon remains 'top pick' in defense sector, says Bernstein
Bernstein analyst Douglas Harned continues to view Raytheon (RTN) as his "top pick" in the defense space in light of recent Q4 results and progress on the defense budget, which is "more positive" following an agreement in Congress on budget top lines for FY18 and FY19, and publication of a President's budget request for FY19. In a research note to investors, Harned said that while yesterday's announcement of 25% tariffs on steel and 10% on aluminum is negative, most defense contracts should be protected by long-term agreements. Raytheon's business mix, with 40% of revenues coming from missile defense and tactical missiles, looks "most positive," he said, but noted that other defense names, including General Dynamics (GD), Huntington Ingalls (HII), Lockheed Martin (LMT) and Northrop Grumman (NOC), are all rated Market Perform given high valuations.
12/12/17
12/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Juno Therapeutics (JUNO) downgraded to Market Perform from Outperform at Wells Fargo, with analyst Jim Birchenough saying that while data for JCAR017 continue to support a potential best-in-class profile in aggressive lymphoma, the current valuation already reflects dominant market positioning over Gilead's (GILD) Yescarta. 2. General Dynamics (GD) downgraded to Underweight from Neutral at JPMorgan, with analyst Seth Seifman saying Gulfstream questions are unlikely to be resolved in the near term. Demand for G500/600 is ok for now, but uncertainty about ultimate production levels and the pace of the learning curve mean the transition will remain a near term overhang, the analyst said. Seifman also downgraded Raytheon (RTN) to Neutral from Underweight. 3. Adobe (ADBE), Barracuda (CUDA), GoDaddy (GDDY), Fortinet (FTNT) and Check Point (CHKP) downgraded to Neutral from Overweight and CoStar Group (CSGP), Imperva (IMPV) and Monotype Imaging (TYPE) downgraded to Underweight from Overweight at JPMorgan by analyst Sterling Auty in conjunction with his 2018 annual outlook for Software Technology. The analyst does not expect the "exceptional performance" in Software during 2017 to repeat in 2018. 4. Spark Therapeutics (ONCE) downgraded to Neutral from Buy at UBS, with analyst Carter Gould seeing a "challenging setup" for the shares after the Phase 1/2 SPK-8011 data in hemophilia A fell short of expectations. The analyst removed SPK-8011, or $29 per share, and early-stage pipeline value, or $12 per share, from his model. He finds it difficult to be more constructive on Spark shares in the near-term. 5. Electronic Arts (EA) downgraded to Buy from Conviction Buy at Goldman Sachs by analyst Christopher Merwin to reflect fewer near-term catalysts around in-game monetization of non-sports titles. To see The Fly's full Street Research coverage, click here.
LMT Lockheed Martin
$336.32

1.07 (0.32%)

01/30/18
BERN
01/30/18
NO CHANGE
Target $392
BERN
Market Perform
Lockheed Martin price target raised to $392 from $343 at Bernstein
Bernstein analyst Douglas Harned raised his price target for Lockheed Martin to $392 from $343 primarily based on a stronger defense budget outlook and higher Missiles & Fire Control growth. The analyst reiterates a Market Perform rating on the shares.
02/06/18
ARGS
02/06/18
NO CHANGE
Target $385
ARGS
Buy
Lockheed Martin price target raised to $385 from $340 at Argus
Argus analyst John Eade raised his price target on Lockheed Martin to $385 and kept his Buy rating, with the stock outperforming relative to the broader market over the past quarter. Eade notes that a "GOP-controlled House, Senate and White House should bode well for defense spending", while the company's management has a history of "managing through challenges". The analyst adds that his new price target assumes "continued strong earnings based on increased U.S. and international defense spending".
01/30/18
WELS
01/30/18
NO CHANGE
Target $355
WELS
Market Perform
Lockheed Martin price target raised to $355 from $340 at Wells Fargo
Wells Fargo analyst Sam Pearlstein raised his price target for Lockheed Martin to $355 from $340 after the company reported Q4 results ahead of the Street helped by higher sales and a lower adjusted tax rate. The analyst reiterates a Market Perform rating on the shares.
GD General Dynamics
$225.75

1.85 (0.83%)

03/19/18
JEFF
03/19/18
NO CHANGE
JEFF
Jefferies sees General Dynamics bid for CSRA persisting despite CACI offer
Jefferies analyst Sheila Kahyaoglu believes General Dynamics' (GD) bid for CSRA (CSRA) offers "considerably less risk" than CACI's competing offer given its all-cash nature. The analyst believes General Dynamics bid will persist given the lower risk. She sees a 25% of the company increasing its offer $40.75 offer for CSRA following CACI's $44 cash and stock bid.
03/19/18
SBSH
03/19/18
NO CHANGE
SBSH
Citi sees CACI shares falling 5% today on CSRA bid
Citi analyst Jonathan Raviv thinks CACI (CACI) shares will fall 5% today toward $150 following the company's competitive takeover bid for CSRA (CSRA) in light of accretion questions, valuation pressure caused by the changed narrative, and resulting high leverage. CACI is levering up more than expected, such that there's no room to boost the cash portion of the bid, Raviv tells investors in a research note.
02/26/18
COWN
02/26/18
NO CHANGE
Target $253
COWN
Outperform
General Dynamics price target raised to $253 from $230 at Cowen
Cowen analyst Cai von Rumohr raised his price target on General Dynamics (GD) and said it is now his number one defense pick. The analyst cited improving business jet demand, the strongest 2019 Department of Defense budget request, and the accretive CSRA (CSRA) acquisition. von Rumohr reiterated his Outperform rating on General Dynamics shares.
UTX United Technologies
$127.68

0.48 (0.38%)

03/19/18
UBSW
03/19/18
NO CHANGE
Target $155
UBSW
Buy
United Technologies break-up likely unless stock rallies significantly, says UBS
A break-up of United Technologies is likely unless the stock appreciates significantly, UBS analyst Steven Winoker tells investors in a research note following the company's investor day. The analyst's break-up valuation improved to $154 per share at the current midpoint, from $146 last week, following United's comments. Winoker does see advantages to United Technologies' scale as one company and has concerns "with potential disruption/ inefficiencies," but he adds: "at the end of the day, we think UTX will break-up if its value is not realized in its current form." The analyst keeps a Buy rating on the shares with a $155 price target.
03/15/18
UBSW
03/15/18
NO CHANGE
Target $155
UBSW
Buy
United Technologies break-up not worth disruption, says UBS
UBS analyst Steven Winoker said he does not think it is worth breaking up United Technologies at this point as it will not be worth the disruption in business and he sees only a slight increase in the sum-of-the-parts valuation. However, he still sees roughly 20% upside in the shares. Winoker reiterated his Buy rating and $155 price target on United Technologies shares.
02/15/18
LEHM
02/15/18
INITIATION
Target $157
LEHM
Overweight
United Technologies initiated with an Overweight at Barclays
Barclays analyst Julian Mitchell started United Technologies with an Overweight rating and $157 price target. The analyst initiated 24 Multi-Industry companies with a Neutral sector view.
02/09/18
02/09/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Twitter (TWTR) upgraded to Sector Perform from Underperform at RBC Capital with analyst Mark Mahaney saying the fourth quarter revenue and EBITDA were materially better than expected, and while MAU's were below consensus, DAU's grew for the first time at a double-digit rate. 2. iRobot (IRBT) upgraded to Outperform from Market Perform at Raymond James with analyst Mark Strouse saying he sees a more balanced risk/reward following the recent pullback in the shares. 3. Regeneron (REGN) upgraded to Outperform from Neutral at Baird with analyst Brian Skorney noting its selloff since last year and believes its valuation has reached a point where the selloff is overdone. 4. Teva (TEVA) upgraded to Sector Perform from Underperform at RBC Capital with analyst Randall Stanicky saying the 11% sell-off in the stock price following the company's guidance update has removed the debate around 2018 EBITDA target and sees limited downside from the current levels. 5. United Technologies (UTX) upgraded to Buy from Hold at Argus with analyst John Eade saying the company remains a leader in a number of global industries and should continue to benefit from population growth and middle class expansion in developing markets. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
NOC Northrop Grumman
$348.24

3.31 (0.96%)

03/12/18
SBSH
03/12/18
UPGRADE
Target $405
SBSH
Buy
Northrop Grumman resmed with a Buy from Neutral at Citi
Citi analyst Jonathan Raviv resumed coverage of Northrop Grumman (NOC) and upgraded the shares to Buy from Neutral. The pending Orbital (OA) acquisition changes the story in Northrop's favor by enabling modest margin expansion while the company maintains attractive growth, Raviv tells investors in a research note. The analyst raised his price target for the shares to $405 from $280.
02/20/18
02/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Snap (SNAP) downgraded to Sell from Neutral at Citi with analyst Mark May saying the recent flagship app redesign could produce positive long-term benefits, but the "significant jump" in negative app reviews since the redesign was pushed out a few weeks could result in a decline in users and user engagement, and could negatively impact financial results. 2. Wingstop (WING) downgraded to Neutral from Outperform at Baird with analyst David Tarantino citing the recent surge in the shares, which has left less room for upside on a near-term basis. 3. Northrop Grumman (NOC) downgraded to Buy from Conviction Buy at Goldman Sachs with analyst Noah Poponak citing valuation. 4. JPMorgan sees few catalysts for Shire (SHPG), downgrades shares to Neutral with analyst James Gordon saying he sees few catalysts in 2018 and 2019 beyond a potential NeuroScience spinoff, which he does not see as creating fundamental value. 5. Teck Resources (TECK) downgraded to Neutral from Outperform at Macquarie with analyst Matt Murphy citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/20/18
GSCO
02/20/18
DOWNGRADE
GSCO
Buy
Northrop Grumman downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman analyst Noah Poponak removed Northrop Grumman from the Conviction Buy List and maintained a Buy rating and $395 price target citing valuation. The analyst continues to view Northrop as a core holding but struggles to see substantial near-term upside from current levels.
BAESY BAE Systems
$33.04

0.162 (0.49%)

10/03/17
BREN
10/03/17
DOWNGRADE
BREN
Hold
BAE Systems downgraded to Hold from Buy at Berenberg
Berenberg analyst Charlotte Keyworth downgraded BAE Systems to Hold with a reduced price target of 600p. The analyst sees only modest earnings growth for BAE over two years.
09/06/17
STFL
09/06/17
NO CHANGE
STFL
Stifel says United Tech deal strategic, not a sign of M&A 'floodgates opening'
Stifel analyst Joseph DeNardi said one of the only risks he sees to defense stocks' multiples would be a shift in cash deployment strategy from a focus on dividends and buybacks to M&A. However, he views United Technologies' (UTX) planned acquisition of Rockwell Collins (COL) as strategic and largely focused on its desire to regain leverage against Boeing (BA) and Airbus (EADSY) and not indicative of the M&A "floodgates opening" in the defense sector. Other publicly traded companies in the defense space include BAE Systems (BAESY), General Dynamics (GD), Lockheed Martin (LMT), Northrop Grumman (NOC) and Raytheon (RTN).
02/23/18
JPMS
02/23/18
DOWNGRADE
JPMS
Underweight
BAE Systems downgraded to Underweight from Neutral at JPMorgan
JPMorgan analyst David Perry downgraded BAE Systems to Underweight and lowered his price target for the shares to 550p from 555p. The company's "lackluster" guidance for 2018 suggests it will continue to underperform its peers in U.S. defense and in European civil aero, Perry tells investors in a research note. He sees BAE's "long-term underperformance" versus peers continuing in 2018.
01/10/18
UBSW
01/10/18
UPGRADE
UBSW
Buy
BAE Systems upgraded to Buy from Neutral at UBS
UBS analyst Celine Fornaro upgraded BAE Systems to Buy with an increased price target of 670p. The stock's valuation on a cash flow basis is "undemanding" following the pension deficit review and the confirmation of the Qatar order, the analyst contends.
BA Boeing
$337.62

5.86 (1.77%)

03/13/18
JEFF
03/13/18
NO CHANGE
Target $400
JEFF
Buy
Boeing booked 21 widebody orders in February, says Jefferies
Jefferies analyst Sheila Kahyaoglu says the most incremental item in Boeing's February orders report was the booking of 21 widebody orders, including three legacy 777s. The company is adding to its widebody backlog, Kahyaoglu tells investors in a research note. She notes that at current production rates, on average Boeing has more than seven years of production in backlog. The analyst sees support for upcoming rate increases and keeps a Buy rating on Boeing shares with a $400 price target.
03/14/18
JPMS
03/14/18
NO CHANGE
JPMS
Spirit AeroSystems, Boeing weakness appears overdone, says JPMorgan
JPMorgan analyst Seth Seifman said he is not surprised that Spirit AeroSystems (SPR) would underperform after the company made comments at the firm's Aviation, Transportation and Industrials Conference about 737 cost pressure in Q1. He also believes the decline in the stock, as well as in shares of Boeing (BA), appears overdone. He thinks Spirit is "taking a hit" now so that it can meet its commitments to Boeing, noting that the company has maintained its earnings outlook for the year and has a history of conservatism. Seifman added that he does not think this morning's 737 MAX news is the only factor weighing on Boeing and Spirit, however, as reports that President Trump is considering $60B of tariffs on Chinese goods are "likely not helping," but he still thinks a rupture in Boeing's relationship with China is unlikely.
02/13/18
EDJN
02/13/18
UPGRADE
EDJN
Buy
Boeing upgraded to Buy from Hold at Edward Jones
02/13/18
02/13/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. JPMorgan (JPM) upgraded to Outperform from Market Perform at Keefe Bruyette with analyst Brian Kleinhanzl saying he views the recent pullback in the shares as a buying opportunity. 2. Total (TOT) upgraded to Overweight from Equal Weight at Morgan Stanley and to Strong Buy from Outperform at Raymond James. 3. Celgene (CELG) upgraded to Overweight from Equal Weight at Barclays with analyst Geoff Meacham saying the current valuation largely reflects the risk. 4. Quest Diagnostics (DGX) upgraded to Outperform from Neutral at Credit Suisse with analyst A.J. Rice saying he believes the company has "substantial runway on several fronts," including its Optum partnership related to revenue cycle management, which he believes could reduce bad debts and claims denials. 5. Boeing (BA) upgraded to Buy from Hold at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

02:50
09/21/18
09/21
02:50
09/21/18
02:50
General news
FX Action: The dollar and yen have continued to underperform »

FX Action: The dollar and…

02:10
09/21/18
09/21
02:10
09/21/18
02:10
General news
FX Action: USD-JPY has lifted to a fresh two-month high »

FX Action: USD-JPY has…

01:45
09/21/18
09/21
01:45
09/21/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap: Stock…

AYI

Acuity Brands

$161.46

3.9 (2.48%)

21:35
09/20/18
09/20
21:35
09/20/18
21:35
Upgrade
Acuity Brands rating change at Wells Fargo »

Acuity Brands upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

TTNP

Titan Pharmaceuticals

$0.50

-0.08 (-13.79%)

21:34
09/20/18
09/20
21:34
09/20/18
21:34
Syndicate
Titan Pharmaceuticals raises $9.5M in a public offering »

The securities offered by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MTEM

Molecular Templates

$5.81

-0.44 (-7.04%)

21:31
09/20/18
09/20
21:31
09/20/18
21:31
Syndicate
Molecular Templates 8.2M share Secondary priced at $5.50 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 21

    Sep

YMAB

Y-mAbs Therapeutics

$0.00

(0.00%)

21:30
09/20/18
09/20
21:30
09/20/18
21:30
Syndicate
Y-mAbs Therapeutics 6M share IPO priced at $16.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

VKTX

Viking Therapeutics

$18.92

-0.72 (-3.67%)

21:28
09/20/18
09/20
21:28
09/20/18
21:28
Syndicate
Viking Therapeutics 9.5M share Secondary priced at $18.50 »

William Blair, SunTrust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 21

    Sep

TWIN

Twin Disc

$23.33

0.34 (1.48%)

21:28
09/20/18
09/20
21:28
09/20/18
21:28
Syndicate
Twin Disc 1.333M share Secondary priced at $22.50 »

Baird and Oppenheimer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

FTCH

Farfetch

$0.00

(0.00%)

21:26
09/20/18
09/20
21:26
09/20/18
21:26
Syndicate
Farfetch 44.244M share IPO priced at $20.00, above the range »

Goldman Sachs, JPMorgan,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 21

    Sep

CRSP

Crispr Therapeutics

$48.90

-3 (-5.78%)

21:25
09/20/18
09/20
21:25
09/20/18
21:25
Syndicate
Crispr Therapeutics 4.211M share Secondary priced at $47.50 »

Goldman Sachs, Piper…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 21

    Sep

MDCA

MDC Partners

$4.55

0.25 (5.81%)

21:08
09/20/18
09/20
21:08
09/20/18
21:08
Hot Stocks
MDC Partners to evaluate strategic alternatives »

MDC Partners announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GWRE

Guidewire

$101.71

0.16 (0.16%)

20:27
09/20/18
09/20
20:27
09/20/18
20:27
Hot Stocks
Guidewire sees 5-year target revenue of about $1.3B »

Sees % subscription of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

AVMXY

Avita Medical

$0.00

(0.00%)

20:13
09/20/18
09/20
20:13
09/20/18
20:13
Hot Stocks
Avita Medical announces FDA approval of RECELL in burn treatment »

AVITA Medica announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LTS

Ladenburg Thalmann

$2.36

-0.03 (-1.26%)

20:05
09/20/18
09/20
20:05
09/20/18
20:05
Hot Stocks
Ladenburg Thalmann CEO to serve as chairman »

Ladenburg Thalmann…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

19:25
09/20/18
09/20
19:25
09/20/18
19:25
Conference/Events
Morgan Stanley multi-industrial analysts hold analyst/industry conference call »

U.S. Electrical Equipment…

SPY

SPDR S&P 500 ETF Trust

$293.53

2.31 (0.79%)

, SPX

S&P 500

$0.00

(0.00%)

19:15
09/20/18
09/20
19:15
09/20/18
19:15
General news
Trump's former lawyer Cohen met with Mueller multiple times, ABC says »

President Donald…

SPY

SPDR S&P 500 ETF Trust

$293.53

2.31 (0.79%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCS

Steelcase

$16.10

0.8 (5.23%)

, ACAD

Acadia

$19.08

3.97 (26.27%)

19:09
09/20/18
09/20
19:09
09/20/18
19:09
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS:…

SCS

Steelcase

$16.10

0.8 (5.23%)

ACAD

Acadia

$19.08

3.97 (26.27%)

TXN

Texas Instruments

$108.50

1.14 (1.06%)

MCD

McDonald's

$160.84

1.65 (1.04%)

RDS.A

Royal Dutch Shell

$66.83

0.57 (0.86%)

PIR

Pier 1 Imports

$1.80

0.045 (2.56%)

UNFI

United Natural Foods

$33.83

0.54 (1.62%)

MU

Micron

$46.06

1.01 (2.24%)

SGH

Smart Global

$30.44

0.7 (2.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 20

    Sep

  • 20

    Sep

  • 21

    Sep

  • 24

    Sep

  • 24

    Sep

  • 25

    Sep

  • 01

    Oct

  • 04

    Oct

  • 10

    Oct

  • 28

    Oct

KORS

Michael Kors

$72.72

-0.33 (-0.45%)

19:01
09/20/18
09/20
19:01
09/20/18
19:01
Hot Stocks
Michael Kors names Andrea Pesaresi head of Men's business »

Michael Kors Holdings is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MDT

Medtronic

$97.47

1.01 (1.05%)

, MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

19:00
09/20/18
09/20
19:00
09/20/18
19:00
Hot Stocks
Medtronic to acquire Mazor Robotics for $58.50 per ADS, or about $1.64B »

Medtronic (MDT) and Mazor…

MDT

Medtronic

$97.47

1.01 (1.05%)

MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

MDT

Medtronic

$97.47

1.01 (1.05%)

, MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

18:59
09/20/18
09/20
18:59
09/20/18
18:59
Hot Stocks
Breaking Hot Stocks news story on Medtronic, Mazor Robotics »

Medtronic to acquire…

MDT

Medtronic

$97.47

1.01 (1.05%)

MZOR

Mazor Robotics

$52.70

2.44 (4.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

ACAD

Acadia

$19.08

3.97 (26.27%)

18:54
09/20/18
09/20
18:54
09/20/18
18:54
Upgrade
Acadia rating change at Piper Jaffray »

Acadia upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ACAD

Acadia

$19.08

3.97 (26.27%)

18:48
09/20/18
09/20
18:48
09/20/18
18:48
Upgrade
Acadia rating change at Piper Jaffray »

Acadia upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SONA

Southern National Bancorp

$16.89

0.13 (0.78%)

18:45
09/20/18
09/20
18:45
09/20/18
18:45
Hot Stocks
Southern National Bancorp names Jeffrey Karafa CFO »

Southern National Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$298.32

-0.63 (-0.21%)

18:44
09/20/18
09/20
18:44
09/20/18
18:44
Periodicals
Tesla VP of global supply management O'Connor to leave company, Bloomberg says »

Liam O'Connor,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 26

    Sep

  • 29

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.